Exogenous SDF-1α Protects Human Myocardium from Hypoxia-Reoxygenation Injury via CXCR4

Short- and Long-Term Cause of Death in Patients Treated With Primary PCI for STEMI

(2014) Frants Pedersen et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Stromal derived factor 1α: A chemokine that delivers a two-pronged defence of the myocardium

(2014) Daniel I. Bromage et al.   PHARMACOLOGY & THERAPEUTICS

Remote ischaemic preconditioning involves signalling through the SDF-1α/CXCR4 signalling axis

(2013) Sean M. Davidson et al.   BASIC RESEARCH IN CARDIOLOGY

SDF-1 in myocardial repair

(2012) M S Penn et al.   GENE THERAPY

SDF-1/CXCR4 mediates acute protection of cardiac function through myocardial STAT3 signaling following global ischemia/reperfusion injury

(2011) Chunyan Huang et al.   AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY

Role of the SDF-1-CXCR4 axis in stem cell-based therapies for ischemic cardiomyopathy

(2010) Marc-Michael Zaruba et al.   EXPERT OPINION ON BIOLOGICAL THERAPY